News Breaks |
|
|
| December 20, 2012 |
| 08:17 EDT |  | ACUR | Acura Pharma submits Investigational NDA
Acura Pharmaceuticals announced that an Investigational New Drug application, or IND, has been filed with the FDA to allow clinical testing of Acura's hydrocodone bitartrate with acetaminophen formulated with Aversion Technology. Clinical testing can commence under the IND 30 days following the IND filing unless questions are raised by the FDA. An open IND is required for Acura to initiate intranasal abuse liability testing in recreational drug users of the crushed drug product. |
|
|
News For ACUR From The Last 14 Days Check below for free stories on ACUR the last two weeks. |
|
|
| May 24, 2013 |
| 07:20 EDT |  | ACUR | Acura Pharma management to meet with Roth Capital
Meetings to be held in New York/Boston on May 28-30 hosted by Roth Capital. |
|
| May 17, 2013 |
| 11:09 EDT | | ACUR | Acura Pharma mentioned positively by Seeking Alpha contributor
Reference Link |
|
| May 14, 2013 |
| 08:58 EDT |  | ACUR | Acura Pharma initiated with a Buy at Roth Capital
Target $4.50. |
|
|
|
|
|
